Anatara Lifesciences Ltd (ASX:ANR)
Steven Lydeamore
CEO
Market Cap (AUD): 9.94M
Sector: Health Care
Last Trade (AUD):
0.14 +0 (+0%)
Tab Bar
1. About
Anatara Lifesciences Ltd (ASX:ANR) is developing and commercialising innovative, evidence-based solutions for gastrointestinal health.
Anatara is focused on building a portfolio of human gastrointestinal health products, with lead product GaRP (Gastrointestinal ReProgramming) being a dietary supplement with a range of potential indications for the relief of gastrointestinal tract (GIT) symptoms and conditions.